Eptifibatide
Generic medicine reference
Not yet clinically reviewed
This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.
Overview
Eptifibatide helps to prevent platelets in your blood from sticking together and forming a blood clot. An unwanted blood clot can occur with certain heart or blood vessel conditions.
Eptifibatide is used to prevent blood clots or heart attack in people with severe chest pain or other conditions, and in those who are undergoing a procedure called angioplasty (to open blocked arteries).
Eptifibatide may also be used for purposes not listed in this medication guide.
Indications
Eptifibatide helps to prevent platelets in your blood from sticking together and forming a blood clot. An unwanted blood clot can occur with certain heart or blood vessel conditions.
Eptifibatide is used to prevent blood clots or heart attack in people with severe chest pain or other conditions, and in those who are undergoing a procedure called angioplasty (to open blocked arteries).
Eptifibatide may also be used for purposes not listed in this medication guide.
Contraindications
You should not use eptifibatide if you are allergic to it, or if you have:
kidney failure and you are on dialysis; severe or uncontrolled high blood pressure; a bleeding or blood-clotting disorder, such as hemophilia or thrombocytopenia ; if you have had a stroke or any type of bleeding within the past 30 days; if you have had any type of surgery, injury, or medical emergency within the past 6 weeks; or if you have or will soon receive treatment with similar medications such as abciximab (ReoPro) or tirofiban (Aggrastat).
To make sure you can safely receive eptifibatide, tell your doctor if you have kidney disease.
Eptifibatide is not expected to be harmful to an unborn baby. However, aspirin is sometimes given with eptifibatide, and aspirin can cause bleeding when it is taken during the last 3 months of pregnancy. Aspirin can also cause side effects in a newborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.
It is not known whether eptifibatide passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.
Side Effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Tell your caregivers right away if you have:
a light-headed feeling, like you might pass out; any bleeding that will not stop; bleeding around your IV or catheter, or in any place where your skin has been punctured with a needle; red or pink urine; or signs of stomach bleeding --bloody or tarry stools, coughing up blood or vomit that looks like coffee grounds.
The risk of bleeding may be higher in older adults.
Common side effects of eptifibatide may include:
bleeding; or feeling lightheaded.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Warnings
You should not receive eptifibatide if you are also being treated with similar medications such as abciximab (ReoPro) or tirofiban ( Aggrastat ).
You should not receive eptifibatide if: you have severe or uncontrolled high blood pressure ; you are on dialysis due to kidney failure ; you have a bleeding or blood-clotting disorder; you had a stroke or any type of bleeding within the past 30 days; or you had any type of surgery, injury, or medical emergency within the past 6 weeks.
Tell your doctor if you are pregnant or plan to become pregnant during treatment with eptifibatide and aspirin.
High Risk Groups
You should not receive eptifibatide if you are also being treated with similar medications such as abciximab (ReoPro) or tirofiban ( Aggrastat ).
You should not receive eptifibatide if: you have severe or uncontrolled high blood pressure ; you are on dialysis due to kidney failure ; you have a bleeding or blood-clotting disorder; you had a stroke or any type of bleeding within the past 30 days; or you had any type of surgery, injury, or medical emergency within the past 6 weeks.
Tell your doctor if you are pregnant or plan to become pregnant during treatment with eptifibatide and aspirin.
Adult Dosage
180 mcg/kg (180 (180)) As recommended. IV — This loading dose of is given over 1 to 2 minutes immediately after diagnosis, followed by continuous i.v.-infusion of 2µg/kg and minute until either hospital discharge or initiation of coronary artery bypass grafting, or for up to 72 hours. At least 4 hours before discharge all local or systemic bleedings should have been controlled and terminated.
Child Dosage
No child dosage information is recorded for this medicine yet.
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
Tell your doctor about all your current medicines and any you start or stop using, especially:
NSAIDs ( nonsteroidal anti-inflammatory drugs )--aspirin, ibuprofen (Advil, Motrin), naproxen (Aleve), celecoxib , diclofenac , indomethacin , meloxicam , and others; a blood thinner --warfarin, Coumadin , Jantoven ; or any other medicines to treat or prevent blood clots --Plavix, Pradaxa, Xarelto, Ticlid, and others.
This list is not complete. Other drugs may interact with eptifibatide, including prescription and over-the-counter medicines, vitamins, and herbal products . Not all possible interactions are listed in this medication guide.
Storage
No storage information is recorded for this medicine yet.
Available Brands in Pakistan
No active brands are currently recorded for this generic.
2 records are present but flagged "Unverified / Legacy" and excluded.